1 The primary efficacy outcome
was a composite of acute limb ischemia, major amputation of a
2 The primary study outcome
was a composite of adjudicated major arterial or venous throm
3 The primary outcome
was a composite of all-cause death and unplanned hospitalizat
4 The primary outcome
was a composite of all-cause mortality, ACS, ischemia-driven
5 primary outcome, referred to as "disability-free survival,"
was a composite of all-cause mortality, dementia, or persiste
6 The primary safety endpoint
was a composite of all-cause mortality, disabling stroke, lif
7 The primary outcome
was a composite of appropriate and timely interventions for t
8 The primary outcome
was a composite of atherosclerotic cardiovascular events (myo
9 Our primary endpoint
was a composite of cardiovascular death or first hospital adm
10 The primary efficacy measure
was a composite of cardiovascular death, nonfatal myocardial
11 The primary end point
was a composite of cardiovascular death, spontaneous (nonproc
12 The primary end point
was a composite of cardiovascular deaths or hospitalizations
13 Primary outcome
was a composite of CVEs including fatal/nonfatal ischemic str
14 The primary outcome
was a composite of death from any cause or a requirement for
15 The first key secondary outcome
was a composite of death from cardiovascular causes or hospit
16 The primary outcome
was a composite of death from cardiovascular causes, myocardi
17 The first primary outcome
was a composite of death from cardiovascular causes, stroke,
18 The primary outcome
was a composite of death or major postoperative complications
19 The primary outcome
was a composite of death or neurodevelopmental impairment (co
20 The primary outcome
was a composite of death or nonfatal myocardial infarction.
21 The primary outcome
was a composite of death within 7 days or admission to the ne
22 The primary outcome
was a composite of death, major cardiovascular events (stroke
23 The primary endpoint
was a composite of death, MI, or stroke during 1-year follow-
24 A key secondary outcome
was a composite of death, nonfatal myocardial infarction, or
25 The primary safety outcome
was a composite of death, stroke, or serious adverse events r
26 The primary end point
was a composite of efficacy and safety measures, including ef
27 The outcome
was a composite of estimated GFR halving and graft loss.
28 In the prospective cohort, the primary end point
was a composite of in-hospital mortality, renal replacement t
29 The primary safety outcome
was a composite of intracranial hemorrhage or gastrointestina
30 The primary end point
was a composite of intubation or death in time-to-event analy
31 The primary endpoint
was a composite of intubation or death.
32 The primary effectiveness outcome
was a composite of ischemic stroke or systemic embolism.
33 The primary end point
was a composite of malignant ventricular arrhythmia and end-s
34 -analysis, as for the original studies, the primary outcome
was a composite of maternal or perinatal outcome (either mate
35 The primary outcome
was a composite of mortality or major cardiovascular event [n
36 The primary endpoint
was a composite of nonfatal AMI, unscheduled revascularizatio
37 The outcome
was a composite of nonfatal coronary heart disease, stroke, t
38 The endpoint
was a composite of obesity-related cancers, defined per the I
39 Primary endpoint
was a composite of occurrence of death or new organ failure i
40 The primary endpoint
was a composite of peri-procedural in-hospital or post-discha
41 The primary outcome
was a composite of postoperative pulmonary complications with
42 Primary outcome
was a composite of severe adverse perinatal outcomes: mortali
43 The primary outcome
was a composite of stroke or death within 30 days.
44 The secondary outcome was 1-year SVG failure, which
was a composite of SVG occlusion, SVG revascularization, myoc
45 he primary efficacy outcome of major venous thromboembolism
was a composite of symptomatic distal or proximal deep-vein t
46 Primary outcome
was a composite of the first recurrent ischemic stroke or TIA
47 The primary outcome
was a composite of the predictive ability of ML algorithms of
48 The primary endpoint
was a composite of the proportion of participants with confir
49 The primary outcome
was a composite of time to the first occurrence of cardiovasc
50 The primary outcome
was a composite of total hospitalisations for heart failure a